drugset
drugset / Trial / NCT03262038

Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?

NCT03262038 ↗

Phase 4 Terminated 46 enrolled University of Michigan
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a prospective randomized, double-blind, placebo-controlled study to compare the incidence and intensity of ITM-induced pruritus and nausea/vomiting using pre-emptive IV ondansetron, followed by scheduled Around The Clock (ATC) ondansetron vs. our control group, where pruritus and PONV are treated with PRN only medications.

Timeline

Start
2017-12-07
Primary completion
2019-08-20
Completion
2019-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 0.1 mg/kg Intravenous

Indications

No indication recorded.